Last Updated : Monday, July 6, 2020 13:05:06

News of Licenses | Approvals | Permissions in Gujarat

In US, GRANULES PHARMA recalls tablets to control blood-sugar levels

CHANTILLY (VIRGINIA, US) / HYDERABAD / MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges, Hyderabad headquartered Granules India Ltd said of its wholly owned subsidiary and US arm Granules Pharmaceuticals Inc., having issued voluntary nationwide recall in US markets of Metformin Hydrochloride Extended Release Tablets USP, 750 mg

CADILA HEALTH gets DCGI-CDSCO nod for COVID19 vaccine’s human trials

AHMEDABAD / MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges, Pankaj Patel led healthcare service provider and pharmaceutical & wellness products manufacturing Zydus Group’s flagship company Cadila Healthcare Ltd claimed of having successfully completed preclinical development of the company’s vaccine for COVID19 – ZyCoV-D and having received permission

ALEMBIC PHARMA gets USFDA nod to sell tablets to treat bacterial infections

VADODARA (BARODA) / MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges, Vadodara (Baroda) headquartered pharmaceutical products manufacturing Indian company Alembic Pharmaceuticals Ltd said of having got USFDA (US Food & Drugs Administration) nod to sell tablets to cure bacterial infections. In a press-release titled, “Alembic Pharmaceuticals receives USFDA

ALEMBIC PHARMA gets USFDA nod to sell medicine to treat risk of stroke

VADODARA (BARODA) / MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges, Vadodara (Baroda) headquartered Alembic Pharmaceuticals Ltd said of having got USFDA (US Food & Drugs Administration) nod to sell medicine to treat risk of stroke and allied illness. In a press-release titled, “Alembic Pharmaceuticals receives USFDA Tentative

CIPLA gets DCGI nod to sell CIPREMI (Remdesivir lyophilized powder for injection)

MUMBAI / RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, pharmaceutical products manufacturing Indian company Cipla Ltd said of having got nod from USFDA to sell Cipremi (remdesivir lyophilized powder for injection 100 mg), which is an approved emergency use authorization (EUA) treatment for patients with severe COVID19 disease. In

GLENMARK gets Indian Regulator’s nod to make & sell COVID19 treatment drug

MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges, Mumbai headquartered pharmaceutical products manufacturing company Glenmark Pharmaceuticals Ltd said of having emerged as the first pharmaceutical company in India to have got regulatory approval for manufacturing & marketing oral antiviral Favipiravir, for treatment of mild to moderate COVID19 disease.

Dr REDDY’s LAB launches medicine to treat prostate cancer in US Market

PRINCETON (NEW JERSEY, US) / HYDERABAD / MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges, Hyderabad headquartered Reddy family owned and managed pharmaceuticals products manufacturing Indian company Dr. Reddy’s Laboratories Ltd said of having got USFDA (US Food & Drugs Administration) nod to sell medicine to treat prostate

Alembic JVC ALEOR DERMA gets USFDA nod to sell gel to treat pimples, cysts

VADODARA (BARODA) / MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges, Vadodara (Baroda) headquartered Amin family owned 100 years old pharmaceutical products manufacturing Indian company Alembic Pharmaceuticals Ltd said of having announced its joint-venture company Aleor Dermaceuticals having received USFDA (US Food & Drugs Administration) nod to sell

GLENMARK PHARMA gets USFDA nod to sell medicine to treat cough, cold

MUMBAI / RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Mumbai headquartered pharmaceutical products manufacturing company Glenmark Pharmaceuticals Ltd said of having got a final nod from USFDA to sell medicine to treat cough and cold. In a press-release titled, “Glenmark Pharmaceuticals receives ANDA approval for Fingolimod Capsules, 0.5 mg”

CADILA HEALTH gets USFDA nod to sell medicine to treat blood disorders

AHMEDABAD / MUMBAI / RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Ahmedabad headquartered Pankaj Patel led healthcare services and pharma & wellness products manufacturing Zydus Group’s flagship company Cadila Healthcare Ltd said of having got USFDA (US Food & Drugs Administration) nod to sell medicine to treat excess iron

ALEMBIC PHARMA gets USFDA nod to sell medicine to treat blood disorders

VADODARA (BARODA) / MUMBAI / RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Vadodara headquartered Amin family owned 100 years old pharmaceutical products manufacturing Indian company Alembic Pharmaceuticals Ltd said of having got a USFDA (US Food & Drugs Administration) nod to sell medicine to treat chronic iron overload in

SUN PHARMA inks EXCL licensing & dist pact for medicine to treat psoriasis

VADODARA (BARODA) / MUMBAI / RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Vadodara (Baroda) headquartered pharmaceutical products manufacturing Indian company Sun Pharmaceutical Industries Ltd said of one of its subsidiaries having inked and entered into an exclusive agreement with London (UK) based Hikma Pharmaceuticals PLC for an exclusive licensing

CADILA HEALTH ink pact with GILEAD SCIENCES to mfr & mkt REMDESIVIR

AHMEDABAD / MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges from Ahmedabad headquartered Pankaj Patel led Zydus Group’s Healthcare Services providing, Pharmaceutical and Wellness products manufacturing Indian company Cadila Healthcare Ltd it said of having inked non-exclusive licensing agreement with Gilead Sciences Inc., to manufacture and market Remdesivir

CAPLIN STERILES gets USFDA nod to sell injection to treat low blood pressure

CHENNAI / MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges, Chennai headquartered pharmaceutical products manufacturing Indian company Caplin Laboratories Ltd said of having got a nod from USFDA (US Food & Drugs Administration) to market to treat hypotension (abnormally low blood pressure). In a press-release titled, “CAPLIN STERILES

BIOCON and MYLAN gets USFDA nod to sell Semglee™, insulin glargine injection

HERTFORDSHIRE (ENGLAND) / PITTSBURGH (PENNSYLVANIA) / BENGALURU / MUMBAI / RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Bengaluru headquartered Dr Kiran Mazumdar Shaw headed Biotechnology and Pharmaceutical products manufacturing Indian company Biocon Ltd jointly with Mylan N.V. said of having got a nod from USFDA (US Food & Drugs

LUPIN gets USFDA nod to sell medicine to treat liver, lung disorders

BALTIMORE (US) / MUMBAI / RAJKOT – In a regulatory filing submitted to the Indian Stock Exchanges, Mumbai headquartered pharmaceutical products manufacturing Indian company Lupin Ltd said of having got USFDA (US Food & Drugs Administration) nod to treat liver and lung disorders. In a press-release titled, “Lupin Receives Approval for Albendazole Tablets USP”, as

Do NOT follow this link or you will be banned from the site!